title: No TWEAK for COPD.
authors.affiliation: Respiratory Therapy Area, GlaxoSmithKline, King of Prussia, PA, USA.
authors.forename: A L
authors.initials: AL
authors.lastname: Lazaar
authors.forename: B E
authors.initials: BE
authors.lastname: Miller
authors.forename: G
authors.initials: G
authors.lastname: Francombe
authors.forename: A
authors.initials: A
authors.lastname: Duvoix
authors.forename: S A
authors.initials: SA
authors.lastname: Natanek
authors.forename: M I
authors.initials: MI
authors.lastname: Polkey
mesh_terms: D000368:Aged; D015415:Biomarkers / Q000097:blood; D001823:Body Composition; D016022:Case-Control Studies; D002986:Clinical Trials as Topic; D015331:Cohort Studies; D000074049:Cytokine TWEAK; D015444:Exercise; D005260:Female; D006801:Humans; D007249:Inflammation; D008297:Male; D008875:Middle Aged; D029424:Pulmonary Disease, Chronic Obstructive / Q000097:blood* / Q000175:diagnosis* / Q000401:mortality / Q000628:therapy*; D052097:Quadriceps Muscle / Q000473:pathology; D048069:Tumor Necrosis Factors / Q000097:blood*
chemical_list: D015415:Biomarkers; D000074049:Cytokine TWEAK; C109743:TNFSF12 protein, human; D048069:Tumor Necrosis Factors